Trial Profile
Prospective, multicenter, randomized study to assess the effect of rivaroxaban in the portal vein thrombosis recanalization and the survival in patients with cirrhosis and portal vein thrombosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- Acronyms TROMBOXABAN
- 25 Sep 2023 Status changed from recruiting to completed.
- 23 Feb 2017 New trial record